Johnson & Johnson's McNeil Agrees To Pay $25 Million In Settlement For Recall Probe
Written By: Rheingold, Valet, Rheingold, Ruffo & Giuffra LLP
On March 10, 2015, Johnson & Johnson's subsidiary McNeil, agreed to pay $25 million and forfeit $5 million, for selling recalled infants' Tylenol, Zyrtec, Benadryl, and other children and infants' over-the-counter medicines. McNeil plead guilty to a misdemeanor violation and failure to file necessary documents during the manufacturing process of the medications.
The U.S. Department of Justice released a statement that detailed the consumer complaints. According to the report, "On or about May 1, 2009, McNeil received a complaint from a consumer regarding the presence of 'black specks in the liquid on the bottom of the bottle of Infants' Tylenol. The foreign material was later identified as including nickel/chromium-rich inclusions, which were not intended ingredients in this OTC liquid drug."